Published in J Med Virol on January 01, 1983
Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J Virol (2001) 1.66
Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain. Infect Immun (1984) 1.36
Functional interferon system is required for clearance of lassa virus. J Virol (2012) 1.05
Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers. Virology (2007) 1.02
Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J Virol (2009) 0.97
Evaluation of Lassa antiviral compound ST-193 in a guinea pig model. Antiviral Res (2011) 0.94
Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever. J Med Virol (2004) 0.88
Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials. PLoS Pathog (2013) 0.87
The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines (2013) 0.84
Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers. Viruses (2012) 0.84
Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines. Expert Rev Vaccines (2016) 0.75
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Clinical recognition and management of patients exposed to biological warfare agents. JAMA (1997) 4.67
ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92
Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis (1999) 3.47
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J Virol (2004) 2.72
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69
Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Suppl (1996) 2.63
Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest (2000) 2.45
Differentiation of filoviruses by electron microscopy. Virus Res (1995) 2.39
Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis (1980) 2.38
The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab Invest (2001) 2.38
Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med (1996) 2.23
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine (2000) 1.95
Experimental studies of arenaviral hemorrhagic fevers. Curr Top Microbiol Immunol (1987) 1.83
Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. J Comp Pathol (1992) 1.78
Lymphocytic choriomeningitis virus. A neglected pathogen of man. Arch Pathol Lab Med (1992) 1.71
Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Arch Pathol Lab Med (1997) 1.61
Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev Infect Dis (1989) 1.58
Strengthening national preparedness for smallpox: an update. Emerg Infect Dis (2001) 1.52
Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs. Infect Immun (1981) 1.51
Pathogenesis of Lassa virus infection in guinea pigs. Infect Immun (1982) 1.47
Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc Natl Acad Sci U S A (1991) 1.37
Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain. Infect Immun (1984) 1.36
Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys. Lab Anim Sci (1992) 1.36
Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett (2001) 1.32
Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. J Infect Dis (1984) 1.30
Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis (1999) 1.29
Analysis of the monkeypox virus genome. Virology (2002) 1.27
Growth curves and clearance rates of virulent and benign Venezuelan encephalitis viruses in hamsters. Infect Immun (1973) 1.26
Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A. Vaccine (1999) 1.25
Selective clearance of a benign clone of Venezuelan equine encephalitis virus from hamster plasma by hepatic reticuloendothelial cells. J Infect Dis (1975) 1.24
Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization. Trans R Soc Trop Med Hyg (1985) 1.23
Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am J Trop Med Hyg (1994) 1.21
Observations of equines, humans and domestic and wild vertebrates during the 1969 equine epizootic and epidemic of Venezuelan encephalitis in Guatemala. Am J Epidemiol (1972) 1.18
Histopathology and distribution of viral antigens in hamsters infected with virulent and benign Venezuelan encephalitis viruses. Am J Pathol (1973) 1.18
Correlates to increased lethality of attenuated Venezuelan encephalitis virus vaccine for immunosuppressed hamsters. Infect Immun (1974) 1.18
Use of immunoelectron microscopy to show Ebola virus during the 1989 United States epizootic. J Clin Pathol (1990) 1.17
Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Trans R Soc Trop Med Hyg (1985) 1.17
Filovirus contamination of cell cultures. Dev Biol Stand (1992) 1.17
Early diagnosis of human Lassa fever by ELISA detection of antigen and antibody. Lancet (1985) 1.12
Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. J Clin Microbiol (1984) 1.11
The potential of 5' nuclease PCR for detecting a single-base polymorphism in Orthopoxvirus. Mol Cell Probes (1997) 1.10
Real-time microchip PCR for detecting single-base differences in viral and human DNA. Anal Chem (1998) 1.08
Interferon induction and sensitivity as correlates to virulence of Venezuelan encephalitis viruses for hamsters. Arch Virol (1976) 1.07
Pediatric Lassa fever: a review of 33 Liberian cases. Am J Trop Med Hyg (1987) 1.07
Prevalence of infection with Junin virus in rodent populations in the epidemic area of Argentine hemorrhagic fever. Am J Trop Med Hyg (1994) 1.06
Patients infected with high-hazard viruses: scientific basis for infection control. Arch Virol Suppl (1996) 1.06
Infection of rhesus and cynomolgus macaques with a rapidly fatal SIV (SIVSMM/PBj) isolate from sooty mangabeys. AIDS Res Hum Retroviruses (1992) 1.03
Endemic Lassa fever in Liberia. I. Clinical and epidemiological aspects at Curran Lutheran Hospital, Zorzor, Liberia. Trans R Soc Trop Med Hyg (1984) 1.03
Pathology of Lassa virus infection in the rhesus monkey. Am J Trop Med Hyg (1982) 1.02
Replication of hemorrhagic fever viruses in monocytic cells. Rev Infect Dis (1989) 1.00
Virulence heterogeneity of a predominantly avirulent Western equine encephalitis virus population. J Gen Virol (1976) 1.00
Experimental Lassa fever virus infection successfully treated with ribavirin. Lancet (1979) 0.99
Homegeneity of Venezuelan encephalitis virion populations of hamster-virulent and benign strains, including the attenuated TC83 vaccine. Infect Immun (1973) 0.98
Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 0.97
Chromatographic separations of alphavirus strains by hydroxylapatite. J Clin Microbiol (1977) 0.96
Molecular characterization and comparison of simian immunodeficiency virus isolates from macaques, mangabeys, and African green monkeys. J Med Primatol (1989) 0.96
Differential alterations in host peripheral polymorphonuclear leukocyte chemiluminescence during the course of bacterial and viral infections. Infect Immun (1980) 0.95
Marburg virus vaccines: comparing classical and new approaches. Vaccine (2001) 0.95
Possible endotoxemia in rabbits after intravenous injection of Staphylococcus aureus enterotoxin B. J Infect Dis (1977) 0.94
Virus-initiated septic shock. Acute death of Venezuelan encephalitis virus-infected hamsters. Lab Invest (1975) 0.94
Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia. Clin Exp Immunol (1980) 0.93
Cardiovascular and pulmonary responses to Pichinde virus infection in strain 13 guinea pigs. Lab Anim Sci (1994) 0.91
Immune serum increases arenavirus replication in monocytes. J Gen Virol (1988) 0.90
Ecologic studies of Venezuelan encephalitis virus and isolations of Nepuyo and Patois viruses during 1968-1973 at a marsh habitat near the epicenter of the 1969 outbreak in Guatemala. Am J Trop Med Hyg (1976) 0.89
A probable endocrine basis for the depression of ketone bodies during infectious or inflammatory state in rats. Endocrinology (1980) 0.89
Characterization of Oliveros virus, a new member of the Tacaribe complex (Arenaviridae: Arenavirus). Am J Trop Med Hyg (1996) 0.88
Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells. Microb Pathog (1990) 0.88
Clinical recognition and management of patients exposed to biological warfare agents. Clin Lab Med (2001) 0.88
Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development. Med Microbiol Immunol (1986) 0.88
Virus-induced pancreatic disease by Venezuelan encephalitis virus. Alterations in glucose tolerance and insulin release. Diabetes (1976) 0.87
Comparative pathology of smallpox and monkeypox in man and macaques. J Comp Pathol (2012) 0.87
Rapid identification of Ebola virus and related filoviruses in fluid specimens using indirect immunoelectron microscopy. J Clin Pathol (1991) 0.86
Association of interleukin-6 in the pathogenesis of acutely fatal SIVsmm/PBj-14 in pigtailed macaques. AIDS Res Hum Retroviruses (1993) 0.86
Vascular clearance of venezuelan equine encephalomyelitis viruses as a correlate to virulence for rhesus monkeys. Arch Virol (1977) 0.86
Comparisons among members of the Venezuelan encephalitis virus complex using hydroxylapatite column chromatography. Am J Epidemiol (1977) 0.86
Studies of the coagulation system in arenaviral hemorrhagic fever: experimental infection of strain 13 guinea pigs with Pichinde virus. Am J Trop Med Hyg (1987) 0.84
Evaluation of vascular clearance as a marker for virulence of alphaviruses: disassociation of rapid clearance with low virulence of venezuelan encephalitis virus strains in guinea pigs. Infect Immun (1977) 0.84
Experimental infection of guinea pigs with Venezuelan hemorrhagic fever virus (Guanarito): a model of human disease. Am J Trop Med Hyg (1996) 0.84
Use of immunoelectron microscopy to demonstrate Francisella tularensis. J Clin Microbiol (1993) 0.84
Characterization of the binding of the TC-83 strain of Venezuelan Equine encephalomyelitis virus to BW-J-M, a mouse macrophage-like cell line. J Gen Virol (1983) 0.83
Correlation between virus-cell receptor properties of alphaviruses in vitro and virulence in vivo. Arch Virol (1979) 0.83
Pancreatic involvement by Venezuelan equine encephalomyelitis virus in the hamster. Am J Pathol (1974) 0.83
Multiple genetic differences between the monkeypox and variola viruses. Dokl Biochem Biophys (2002) 0.82
Endemic Lassa fever in Liberia. II. Serological and virological findings in hospital patients. Trans R Soc Trop Med Hyg (1984) 0.82
Pathogenesis of a Venezuelan encephalitis virus strain lethal for adult white rats. J Med Virol (1978) 0.81
Opsonization of alphaviruses in hamsters. J Med Virol (1983) 0.81
Enzyme-linked immunosorbent assay detection of immunoglobulins G and M to Venezuelan equine encephalomyelitis virus in vaccinated and naturally infected humans. J Clin Microbiol (1988) 0.81
Inhibition of mouse peritoneal macrophage DNA synthesis by infection with the arenavirus Pichinde. Infect Immun (1984) 0.81
Vaccination of macaques with SIV conserved envelope peptides suppressed infection and prevented disease progression and transmission. AIDS Res Hum Retroviruses (1992) 0.80
Radioimmunoassay for quantitation of antibodies to alphaviruses with staphylococcal protein A. J Clin Microbiol (1978) 0.80
Receptor interaction between eastern equine encephalitis virus and chicken embryo fibroblasts. J Virol (1977) 0.78
Antiviral efficacy of pyrazofurin against selected RNA viruses. Antiviral Res (1982) 0.78
Interference between virulent and vaccine strains of Venezuelan encephalitis virus in mixed infections of hamsters. J Gen Virol (1975) 0.78
Virologic investigation of a case of suspected haemorrhagic fever. Res Virol (1995) 0.76
Detection of Ebola-like viruses by immunofluorescence. Lancet (1991) 0.75
Enterotoxic shock in rhesus monkeys. The role of selected bloodborne factors. Circ Res (1978) 0.75
Prevention of transmission of simian immunodeficiency virus from vaccinated macaques that developed transient virus infection following challenge. Vaccine (1993) 0.75
Resolving power in a practical application of preparative sodium dodecyl sulfate polyacrylamide gel electrophoresis: preparation of Eastern encephalitis virus proteins. Anal Biochem (1977) 0.75